-
Published08/10/2025
-
Today18/11/2025
-
Deadline20/11/2025
Utilities
- indicates text translated automatically in your browsing language
34. Generics tender (antibiotics+BMG) Text automatically translated in your browsing language Automatically translated
It is intended to conclude drug-selective discount agreements with pharmaceutical companies within the meaning of § 130a(8) SGB V for the supply of finished medicinal products in accordance with the procurement documents available in electronic form. The award is divided into active substance-related specialist lots. In accordance with the provisions of the Medicines Supply Shortage Control and Supply Improvement Act (ALBVVG), these lots are divided into two lots (EU lot/global lot) for non-patent antibiotics, § 130a(8a) SGB V. A contractual partner is sought for the EU lot, but two contractual partners in the global lot. The individual lots can be found in the tender file (Annex 1). With regard to the details, reference is made to the terms of the contract and the price sheets for the individual lots as part of the procurement documents. Text automatically translated in your browsing language Automatically translated
https://www.dtvp.de/Satellite/notice/CXP4YRZ52KP
https://www.dtvp.de/Satellite/notice/CXP4YRZ52KP
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.